8 results on '"Van Malderen, Sophie C. H."'
Search Results
2. What the internist should know about hereditary muscle channelopathies
- Author
-
Bissay, Véronique, primary and Van Malderen, Sophie C. H., additional
- Published
- 2017
- Full Text
- View/download PDF
3. What the internist should know about hereditary muscle channelopathies
- Author
-
Bissay, Véronique and Van Malderen, Sophie C. H.
- Abstract
AbstractObjectives:Non-dystrophic myotonia, periodic paralysis and, to a certain extent, myotonic dystrophies are rare hereditary skeletal muscle channelopathies, charactarized by myotonia or episodic muscle weakness. This review highlights the diagnostic challenges and treatment options.Results: Some of these rare skeletal muscle disorders are associated with a broad range of systemic and nonspecific muscle symptoms. Consequently, patients are often referred to the internist before seeing a neurologist. This article provides clinical clues to better diagnose an tackle these unique disorders.Conclusion: A increased knowledge will reduce the diagnostic delay, improve monitoring and treatment, and might even prevent potentially life-threatening conditions as seen in DM.
- Published
- 2018
- Full Text
- View/download PDF
4. Prolonged right ventricular ejection delay identifies high risk patients and gender differences in Brugada syndrome.
- Author
-
Van Malderen, Sophie C. H., Kerkhove, Dirk, Theuns, Dominic A. M. J., Weytjens, Caroline, Droogmans, Steven, Tanaka, Kaoru, Daneels, Dorien, Van Dooren, Sonia, Meuwissen, Marije, Bonduelle, Maryse, Brugada, Pedro, and Van Camp, Guy
- Subjects
- *
RIGHT heart ventricle , *GENDER differences (Psychology) , *BRUGADA syndrome , *PATHOLOGICAL physiology , *ECHOCARDIOGRAPHY , *PATIENTS , *DISEASE risk factors , *PHYSIOLOGY - Abstract
Background and objectives Right ventricular (RV) conduction delay has been suggested as an underlying pathophysiological mechanism in Brugada syndrome (BS). In this cross-sectional study we non-invasively assessed the value of echocardiographic markers reflecting ventricular ejection delay to further assess electromechanical abnormalities in BS and to identify patients at risk for life-threatening arrhythmic events. Furthermore, we sought to assess differences in ejection delays between genders because male BS patients demonstrate a more malignant clinical phenotype. Methods 124 BS patients (57.3% males) and 62 controls (CTR) (48.4% males) were included. Using Tissue Velocity Imaging, the ejection delay, determined as the time from QRS onset to the onset of the sustained systolic contraction, was measured for both RV free wall (RVED) and lateral LV wall (LVED). From these parameters, the interventricular ejection delay between both walls (IVED) was calculated. Results BS patients had longer RVEDs and IVEDs compared to the CTR. BS patients with a previous history of syncope or spontaneous ventricular arrhythmia showed the longest RVEDs and IVEDs. Male BS patients demonstrated longer RVEDs and IVEDs than females. Male BS patients with malignant events had the longest delays. No significant differences regarding LVED were observed between BS patients and CTR. Conclusions We demonstrated that a previous history of malignant events was associated with longer RVEDs. Our findings supported the RV conduction delay mechanism behind BS and demonstrated for the first time that the predominant malignant male Brugada phenotype might also be the result of a more delayed RV conduction in males. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
5. Case report: Synergetic effect of ischaemia and increased vagal tone inducing ventricular fibrillation in a patient with Brugada syndrome.
- Author
-
Van Malderen SCH, Schultz CJ, and Jordaens L
- Abstract
Background: Brugada syndrome (BS) is a hereditary channelopathy associated with syncope, malignant ventricular arrhythmia, and sudden cardiac death. Right ventricular ischaemia and BS have similar underlying substrates precipitating ventricular tachycardia or fibrillation (VF)., Case Summary: A 72-year-old woman with BS and a stenosis on the proximal right coronary artery received several subsequent implantable cardioverter-defibrillator shocks due to VF during an episode of extreme nausea with vomiting., Discussion: This case report emphasizes on the synergetic effect of mild ischaemia and increased vagal tone on the substrate responsible for BS to create pathophysiological changes precipitating VF., (© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.)
- Published
- 2020
- Full Text
- View/download PDF
6. Prolonged Right Ventricular Ejection Delay in Brugada Syndrome Depends on the Type of SCN5A Variant - Electromechanical Coupling Through Tissue Velocity Imaging as a Bridge Between Genotyping and Phenotyping.
- Author
-
Van Malderen SCH, Daneels D, Kerkhove D, Peeters U, Theuns DAMJ, Droogmans S, Van Camp G, Weytjens C, Biervliet M, Bonduelle M, Van Dooren S, and Brugada P
- Subjects
- Adult, Brugada Syndrome diagnostic imaging, Codon, Nonsense, Cross-Sectional Studies, Echocardiography, Electrochemical Techniques, Female, Genotype, Heart Conduction System diagnostic imaging, Heart Conduction System physiopathology, Humans, Male, Middle Aged, Mutation, Missense, Phenotype, Time Factors, Ventricular Dysfunction, Right diagnostic imaging, Brugada Syndrome physiopathology, NAV1.5 Voltage-Gated Sodium Channel genetics, Ventricular Dysfunction, Right physiopathology
- Abstract
Background: Patients with Brugada syndrome (BrS) and a history of syncope or sustained ventricular arrhythmia have longer right ventricular ejection delays (RVEDs) than asymptomatic BrS patients. Different types ofSCN5Avariants leading to different reductions in sodium current (I
Na ) may have different effects on conduction delay, and consequently on electromechanical coupling (i.e., RVED). Thus, we investigated the genotype-phenotype relationship by measuring RVED to establish whether BrS patients carrying more severeSCN5Avariants leading to premature protein truncation (T) and presumably 100%INa reduction have a longer RVED than patients carrying missense variants (M) with different degrees ofINa reduction.Methods and Results:There were 34 BrS patients (mean [±SD] age 43.3±12.9 years; 52.9% male) carrying anSCN5Avariant and 66 non-carriers in this cross-sectional study. Patients carrying aSCN5Avariant were divided into T-carriers (n=13) and M-carriers (n=21). Using tissue velocity imaging, RVED and left ventricular ejection delay (LVED) were measured as the time from QRS onset to the onset of the systolic ejection wave at the end of the isovolumetric contraction. T-carriers had longer RVEDs than M-carriers (139.3±15.1 vs. 124.8±11.9 ms, respectively; P=0.008) and non-carriers (127.7±17.3 ms, P=0.027). There were no differences in LVED among groups., Conclusions: Using the simple, non-invasive echocardiographic parameter RVED revealed a more pronounced 'electromechanical' delay in BrS patients carrying T variants ofSCN5A.- Published
- 2017
- Full Text
- View/download PDF
7. Comparative study of the failure rates among 3 implantable defibrillator leads.
- Author
-
van Malderen SC, Szili-Torok T, Yap SC, Hoeks SE, Zijlstra F, and Theuns DA
- Subjects
- Aged, Early Diagnosis, Electric Impedance, Equipment Design, Female, Follow-Up Studies, Humans, Male, Middle Aged, Monitoring, Physiologic methods, Netherlands, Registries statistics & numerical data, Remote Sensing Technology methods, Arrhythmias, Cardiac therapy, Defibrillators, Implantable adverse effects, Defibrillators, Implantable classification, Electric Countershock adverse effects, Electric Countershock instrumentation, Electric Countershock methods, Equipment Failure statistics & numerical data
- Abstract
Background: After the introduction of the Biotronik Linox S/SD high-voltage lead, several cases of early failure have been observed., Objective: The purpose of this article was to assess the performance of the Linox S/SD lead in comparison to 2 other contemporary leads., Methods: We used the prospective Erasmus MC ICD registry to identify all implanted Linox S/SD (n = 408), Durata (St. Jude Medical, model 7122) (n = 340), and Endotak Reliance (Boston Scientific, models 0155, 0138, and 0158) (n = 343) leads. Lead failure was defined by low- or high-voltage impedance, failure to capture, sense or defibrillate, or the presence of nonphysiological signals not due to external interference., Results: During a median follow-up of 5.1 years, 24 Linox (5.9%), 5 Endotak (1.5%), and 5 Durata (1.5%) leads failed. At 5-year follow-up, the cumulative failure rate of Linox leads (6.4%) was higher than that of Endotak (0.4%; P < .0001) and Durata (2.0%; P = .003) leads. The incidence rate was higher in Linox leads (1.3 per 100 patient-years) than in Endotak and Durata leads (0.2 and 0.3 per 100 patient-years, respectively; P < .001). A log-log analysis of the cumulative hazard for Linox leads functioning at 3-year follow-up revealed a stable failure rate of 3% per year. The majority of failures consisted of noise (62.5%) and abnormal impedance (33.3%)., Conclusion: This study demonstrates a higher failure rate of Linox S/SD high-voltage leads compared to contemporary leads. Although the mechanism of lead failure is unclear, the majority presents with abnormal electrical parameters. Comprehensive monitoring of Linox S/SD high-voltage leads includes remote monitoring to facilitate early detection of lead failure., (Copyright © 2016. Published by Elsevier Inc.)
- Published
- 2016
- Full Text
- View/download PDF
8. SCN4A variants and Brugada syndrome: phenotypic and genotypic overlap between cardiac and skeletal muscle sodium channelopathies.
- Author
-
Bissay V, Van Malderen SC, Keymolen K, Lissens W, Peeters U, Daneels D, Jansen AC, Pappaert G, Brugada P, De Keyser J, and Van Dooren S
- Subjects
- Adult, Aged, Brugada Syndrome diagnostic imaging, Electrocardiography, Electromyography, Female, Genetic Testing, Humans, Male, Middle Aged, Phenotype, Ultrasonography, Brugada Syndrome genetics, Channelopathies genetics, Genetic Predisposition to Disease, Muscle, Skeletal pathology, Mutation genetics, Myocardium pathology, NAV1.4 Voltage-Gated Sodium Channel genetics
- Abstract
SCN5A mutations involving the α-subunit of the cardiac voltage-gated muscle sodium channel (NaV1.5) result in different cardiac channelopathies with an autosomal-dominant inheritance such as Brugada syndrome. On the other hand, mutations in SCN4A encoding the α-subunit of the skeletal voltage-gated sodium channel (NaV1.4) cause non-dystrophic myotonia and/or periodic paralysis. In this study, we investigated whether cardiac arrhythmias or channelopathies such as Brugada syndrome can be part of the clinical phenotype associated with SCN4A variants and whether patients with Brugada syndrome present with non-dystrophic myotonia or periodic paralysis and related gene mutations. We therefore screened seven families with different SCN4A variants and non-dystrophic myotonia phenotypes for Brugada syndrome and performed a neurological, neurophysiological and genetic work-up in 107 Brugada families. In the families with an SCN4A-associated non-dystrophic myotonia, three patients had a clinical diagnosis of Brugada syndrome, whereas we found a remarkably high prevalence of myotonic features involving different genes in the families with Brugada syndrome. One Brugada family carried an SCN4A variant that is predicted to probably affect function, one family suffered from a not genetically confirmed non-dystrophic myotonia, one family was diagnosed with myotonic dystrophy (DMPK gene) and one family had a Thomsen disease myotonia congenita (CLCN1 variant that affects function). Our findings and data suggest a possible involvement of SCN4A variants in the pathophysiological mechanism underlying the development of a spontaneous or drug-induced type 1 electrocardiographic pattern and the occurrence of malignant arrhythmias in some patients with Brugada syndrome.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.